A. Gatt

1.2k total citations
21 papers, 886 citations indexed

About

A. Gatt is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Gatt has authored 21 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 7 papers in Internal Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Gatt's work include Venous Thromboembolism Diagnosis and Management (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Atrial Fibrillation Management and Outcomes (6 papers). A. Gatt is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (7 papers), Blood Coagulation and Thrombosis Mechanisms (6 papers) and Atrial Fibrillation Management and Outcomes (6 papers). A. Gatt collaborates with scholars based in United Kingdom, Malta and United States. A. Gatt's co-authors include Michael Makris, Joost J. van Veen, Emmanuel Tsochatzis, Marco Senzolo, Giacomo Germani, Andrew K. Burroughs, Anne Riddell, Koichi Iijima, Kanae Iijima‐Ando and Jecko Thachil and has published in prestigious journals such as European Heart Journal, Human Molecular Genetics and Journal of Hepatology.

In The Last Decade

A. Gatt

19 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Gatt United Kingdom 11 339 291 238 198 191 21 886
Maarten Knechtelsdorfer Austria 8 49 0.1× 214 0.7× 115 0.5× 61 0.3× 104 0.5× 13 936
PB Kernoff United Kingdom 12 55 0.2× 72 0.2× 431 1.8× 23 0.1× 52 0.3× 21 822
Hongyu Meng China 15 86 0.3× 164 0.6× 15 0.1× 107 0.5× 93 0.5× 42 611
Mark S. D'Almeida Canada 10 136 0.4× 133 0.5× 69 0.3× 7 0.0× 44 0.2× 16 587
Theodoros Zografos Greece 18 97 0.3× 186 0.6× 22 0.1× 20 0.1× 732 3.8× 67 1.2k
Erdem Koçak Türkiye 18 135 0.4× 303 1.0× 47 0.2× 14 0.1× 73 0.4× 65 789
Jørn Dalsgaard Nielsen Denmark 17 8 0.0× 98 0.3× 287 1.2× 211 1.1× 308 1.6× 44 978
Kenichi Sugioka Japan 23 33 0.1× 231 0.8× 19 0.1× 53 0.3× 1.0k 5.3× 82 1.5k
Stefan Heitmeier Germany 20 8 0.0× 177 0.6× 365 1.5× 478 2.4× 672 3.5× 48 1.2k
J. Zahavi United Kingdom 19 11 0.0× 121 0.4× 316 1.3× 296 1.5× 471 2.5× 37 1.1k

Countries citing papers authored by A. Gatt

Since Specialization
Citations

This map shows the geographic impact of A. Gatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gatt more than expected).

Fields of papers citing papers by A. Gatt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gatt. The network helps show where A. Gatt may publish in the future.

Co-authorship network of co-authors of A. Gatt

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gatt. A scholar is included among the top collaborators of A. Gatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gatt. A. Gatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fischer, Kathelijn, Riitta Lassila, Flora Peyvandi, et al.. (2025). Inhibitor development in nonsevere hemophilia: data from the European Haemophilia Safety Surveillance (EUHASS) registry. Research and Practice in Thrombosis and Haemostasis. 9(4). 102887–102887.
2.
Cuker, Adam, A. Gatt, Nicolas Gendron, et al.. (2024). Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH. Journal of Thrombosis and Haemostasis. 22(9). 2653–2669. 14 indexed citations
3.
Fischer, Kathelijn, Riitta Lassila, Flora Peyvandi, et al.. (2024). Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS). Research and Practice in Thrombosis and Haemostasis. 8(4). 102461–102461. 4 indexed citations
4.
Riva, Nicoletta, et al.. (2023). Navigating through the haemostatic paradox in kidney failure: A practical overview. British Journal of Haematology. 202(2). 230–247. 6 indexed citations
5.
Fischer, Kathelijn, Riitta Lassila, Flora Peyvandi, et al.. (2023). Inhibitor development according to concentrate in severe hemophilia: reporting on 1392 Previously Untreated Patients from Europe and Canada. Research and Practice in Thrombosis and Haemostasis. 7(8). 102265–102265. 9 indexed citations
6.
Gatt, A., et al.. (2022). Long COVID syndrome: a case-control study. European Heart Journal. 43(Supplement_2). 1 indexed citations
7.
Riva, Nicoletta, et al.. (2017). A comparative study using thrombin generation and three different INR methods in patients on Vitamin K antagonist treatment. International Journal of Laboratory Hematology. 39(5). 482–488. 8 indexed citations
8.
Mallett, Susan, Anita Sugavanam, Selina Patel, et al.. (2016). Alterations in coagulation following major liver resection. Anaesthesia. 71(6). 657–668. 42 indexed citations
9.
Chowdary, Pratima, et al.. (2012). Is there an Association between Thrombosis and Fibroids? A single centre experience and literature review. International Journal of Laboratory Hematology. 35(1). e13–6. 8 indexed citations
10.
Iijima, Koichi, A. Gatt, & Kanae Iijima‐Ando. (2010). Tau Ser262 phosphorylation is critical for A 42-induced tau toxicity in a transgenic Drosophila model of Alzheimer's disease. Human Molecular Genetics. 19(15). 2947–2957. 84 indexed citations
11.
Gatt, A., Anne Riddell, Vincenza Calvaruso, et al.. (2010). Enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy. Journal of Thrombosis and Haemostasis. 8(9). 1994–2000. 133 indexed citations
12.
Gatt, A., Andrew K. Burroughs, & Michael Makris. (2010). More on: enhanced thrombin generation in patients with cirrhosis‐induced coagulopathy. Journal of Thrombosis and Haemostasis. 9(3). 613–614.
13.
Tsochatzis, Emmanuel, Marco Senzolo, Giacomo Germani, A. Gatt, & Andrew K. Burroughs. (2009). Systematic review: portal vein thrombosis in cirrhosis. Alimentary Pharmacology & Therapeutics. 31(3). 366–374. 209 indexed citations
14.
Gatt, A., Anne Riddell, Joost J. van Veen, et al.. (2009). Optimizing warfarin reversal – an ex vivo study. Journal of Thrombosis and Haemostasis. 7(7). 1123–1127. 24 indexed citations
15.
Gatt, A. & Pratima Chowdary. (2009). Proceedings of the First Annual Congress of the European Association for Haemophilia and Allied Disorders. Haemophilia. 15(1). 329–336. 2 indexed citations
16.
Gatt, A., Joost J. van Veen, Annette Bowyer, et al.. (2008). Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation. British Journal of Haematology. 142(6). 946–952. 37 indexed citations
17.
Veen, Joost J. van, A. Gatt, Annette Bowyer, et al.. (2008). The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents. International Journal of Laboratory Hematology. 31(2). 189–198. 23 indexed citations
18.
Thachil, Jecko, A. Gatt, & Vanessa Martlew. (2008). Management of surgical patients receiving anticoagulation and antiplatelet agents. British journal of surgery. 95(12). 1437–1448. 80 indexed citations
19.
Veen, Joost J. van, A. Gatt, & Michael Makris. (2008). Thrombin generation testing in routine clinical practice: are we there yet?. British Journal of Haematology. 142(6). 889–903. 171 indexed citations
20.
Gatt, A., et al.. (2007). Hyperhomocysteinemia in women with advanced breast cancer. International Journal of Laboratory Hematology. 29(6). 421–425. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maarten Knechtelsdorfer Breakdown of academic impact, for papers by PB Kernoff Breakdown of academic impact, for papers by Hongyu Meng Breakdown of academic impact, for papers by Mark S. D'Almeida Breakdown of academic impact, for papers by Theodoros Zografos Breakdown of academic impact, for papers by Erdem Koçak Breakdown of academic impact, for papers by Jørn Dalsgaard Nielsen Breakdown of academic impact, for papers by Kenichi Sugioka Breakdown of academic impact, for papers by Stefan Heitmeier Breakdown of academic impact, for papers by J. Zahavi
Rankless by CCL
2026